Rossby Financial’s Terns Pharmaceuticals TERN Stock Holding History

Rossby Financial’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-124	Closed	-$6.55K	–	2337
2026 Q1	$6.55K	Buy	+124	New	+$5.09K	﹤0.01%	1404

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rossby Financial's TERN Position: Q2 2026 in Review

Rossby Financial sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 124 shares — an estimated $6.55K sold.

Rossby Financial first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $6.55K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Rossby Financial reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Rossby Financial sold 124 Terns Pharmaceuticals shares in Q2 2026, an estimated $6.55K.
Rossby Financial first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Rossby Financial's Terns Pharmaceuticals position peaked at $6.55K in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Rossby Financial's 13F filing for Q2 2026, filed 4 Aug 2026.